Literature DB >> 11408960

Prevalence of mental retardation and developmental disabilities: estimates from the 1994/1995 National Health Interview Survey Disability Supplements.

S A Larson1, K C Lakin, L Anderson, N Kwak, J H Lee, D Anderson.   

Abstract

In 1994 and 1995, the National Health Interview Survey included a Disability Supplement (NHIS-D) to collect extensive information about disabilities among individuals sampled as part of annual census-based household interview surveys. Here we describe the development and application of operational definitions of mental retardation and developmental disabilities to items in the NHIS-D to estimate prevalence. In our analyses, we estimate the prevalence of mental retardation in the noninstitutionalized population of the United States to be 7.8 people per thousand (.78%); of developmental disabilities, 11.3 people per thousand (1.13%); and the combined prevalence of mental retardation and/or developmental disabilities to be 14.9 per thousand (1.49%). Differences in prevalence estimates for mental retardation and developmental disabilities and among people of various ages are explored.

Entities:  

Mesh:

Year:  2001        PMID: 11408960

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  30 in total

Review 1.  Learning difficulties: what the neurologist needs to know.

Authors:  C D Rittey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-03       Impact factor: 10.154

Review 2.  The state of synapses in fragile X syndrome.

Authors:  Brad E Pfeiffer; Kimberly M Huber
Journal:  Neuroscientist       Date:  2009-03-26       Impact factor: 7.519

3.  The XLID protein PQBP1 and the GTPase Dynamin 2 define a signaling link that orchestrates ciliary morphogenesis in postmitotic neurons.

Authors:  Yoshiho Ikeuchi; Luis de la Torre-Ubieta; Takahiko Matsuda; Hanno Steen; Hitoshi Okazawa; Azad Bonni
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

4.  Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells.

Authors:  Erin L McMillan; Allison L Kamps; Samuel S Lake; Clive N Svendsen; Anita Bhattacharyya
Journal:  Am J Stem Cells       Date:  2012-06-03

5.  [Health among persons with intellectual disability in Spain: the European POMONA-II study].

Authors:  Rafael Martínez-Leal; Luis Salvador-Carulla; Mencía Ruiz Gutiérrez-Colosía; Margarida Nadal; Ramón Novell-Alsina; Almudena Martorell; Rodrigo G González-Gordón; M Reyes Mérida-Gutiérrez; Silvia Ángel; Luisa Milagrosa-Tejonero; Alicia Rodríguez; Juan C García-Gutiérrez; Amado Pérez-Vicente; José García-Ibáñez; Francisco Aguilera-Inés
Journal:  Rev Neurol       Date:  2011-10-01       Impact factor: 0.870

6.  Potentially Avoidable Hospitalizations among People at Different Activity of Daily Living Limitation Stages.

Authors:  Sophia Miryam Schüssler-Fiorenza Rose; Margaret G Stineman; Qiang Pan; Hillary Bogner; Jibby E Kurichi; Joel E Streim; Dawei Xie
Journal:  Health Serv Res       Date:  2016-03-17       Impact factor: 3.402

7.  Ripple effects of developmental disabilities and mental illness on nondisabled adult siblings.

Authors:  Barbara Wolfe; Jieun Song; Jan S Greenberg; Marsha R Mailick
Journal:  Soc Sci Med       Date:  2014-01-25       Impact factor: 4.634

8.  Dental utilization by adult Medicaid enrollees who have indicators of intellectual and developmental disabilities (IDD).

Authors:  Jane M Chalmers; Raymond A Kuthy; Elizabeth T Momany; Donald L Chi; Robert A Bacon; Scott D Lindgren; Natoshia M Askelson; Peter C Damiano
Journal:  Spec Care Dentist       Date:  2010-12-28

9.  The fragile x mental retardation syndrome 20 years after the FMR1 gene discovery: an expanding universe of knowledge.

Authors:  François Rousseau; Yves Labelle; Johanne Bussières; Carmen Lindsay
Journal:  Clin Biochem Rev       Date:  2011-08

10.  Psychiatric morbidity with focus on obsessive-compulsive disorder in an Israeli cohort of adolescents with mild to moderate mental retardation.

Authors:  Doron Gothelf; Olga Goraly; Sari Avni; Mike Stawski; Inbar Hartmann; Lina Basel-Vanagaite; Alan Apter
Journal:  J Neural Transm (Vienna)       Date:  2008-03-20       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.